Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest update is out from DR Horton ( (DHI) ).
On January 15, 2026, D.R. Horton, Inc. held its Annual Meeting of Stockholders, where shareholders elected eight director nominees to serve until the 2027 annual meeting, indicating continued support for the company’s existing board composition and governance framework. Investors also approved the company’s executive compensation on an advisory basis and ratified Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending September 30, 2026, reinforcing continuity in leadership oversight and financial auditing practices that underpin the company’s operational and reporting stability.
The most recent analyst rating on (DHI) stock is a Hold with a $162.00 price target. To see the full list of analyst forecasts on DR Horton stock, see the DHI Stock Forecast page.
Spark’s Take on DHI Stock
According to Spark, TipRanks’ AI Analyst, DHI is a Neutral.
DR Horton’s overall stock score is driven by solid financial health and a reasonable valuation. However, bearish technical indicators and mixed earnings call sentiment, with concerns over declining sales prices and high cancellation rates, suggest caution. The company’s ability to navigate these challenges will be key to future performance.
To see Spark’s full report on DHI stock, click here.
More about DR Horton
D.R. Horton, Inc. is a U.S.-based homebuilding company that designs, constructs, and sells residential homes, primarily serving homebuyers across various price points and markets nationwide, and is a major player in the domestic housing and residential construction industry.
Average Trading Volume: 3,122,361
Technical Sentiment Signal: Strong Buy
Current Market Cap: $46.53B
See more insights into DHI stock on TipRanks’ Stock Analysis page.